Product Information
METHOTREXATE 2.5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1635 per EA under NDC 62332073036. Its NADAC has been published 93 times since Sep 18, 2024.
Strength
2.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332073036
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA217552On Market Since
6/4/2024
Pharmacological Classes
Price Statistics
The NADAC for METHOTREXATE 2.5 MG TABLET has been published 93 times since Sep 18, 2024, and over the history we have for it it has declined 6.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1635 per EA |
|---|---|
| All-time high | $0.1754 (Oct 16, 2024) |
| All-time low | $0.1530 (Nov 19, 2025) |
| 52-week high | $0.1694 |
| 52-week low | $0.1530 |
| Median price | $0.1611 |
| Average price | $0.1621 |
| Largest weekly change | -7.0% (Nov 20, 2024) |
| Weeks tracked | 93 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHOTREXATE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHOTREXATE 2.5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1635 per EA (NDC 62332073036), effective Jun 24, 2026.
How has the price of METHOTREXATE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHOTREXATE 2.5 MG TABLET has declined 6.8%. It has been tracked across 93 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for METHOTREXATE 2.5 MG TABLET?
Since Sep 18, 2024, the NADAC for METHOTREXATE 2.5 MG TABLET has ranged from a low of $0.1530 (Nov 19, 2025) to a high of $0.1754 (Oct 16, 2024), with a median of $0.1611 per EA.
Are there cheaper alternatives to METHOTREXATE 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as METHOTREXATE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures METHOTREXATE 2.5 MG TABLET?
METHOTREXATE 2.5 MG TABLET (NDC 62332073036) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification